Results 11 to 20 of about 1,082,836 (299)

Adjuvant-containing control arms in pivotal quadrivalent human papillomavirus vaccine trials: Restoration of previously unpublished methodology [PDF]

open access: yes, 2020
Purpose: Trustworthy reporting of quadrivalent human papillomavirus (HPV) vaccine trials is the foundation for assessing the vaccine's risks and benefits.
Bourgeois, Florence   +7 more
core   +1 more source

2013 REU Poster: Investigating the Surface Charge of HIV-1 Virus-like Particles Using Plasmonic Nanoparticles [PDF]

open access: yes, 2013
Poster presentation at REU Summer's End Research Symposium, 2013, by REU participant Ethan Edmonds, SUNY Oneonta - Bjoern Reinhard group, Amin Feizpour lab mentor.In metals, the quanta of oscillations of electrons is referred to as a plasmon.
Edmonds, Ethan
core   +8 more sources

Virus-Like Particle-Mediated Vaccination against Interleukin-13 May Harbour General Anti-Allergic Potential beyond Atopic Dermatitis [PDF]

open access: yes, 2020
Virus-like particle (VLP)-based anti-infective prophylactic vaccination has been established in clinical use. Although validated in proof-of-concept clinical trials in humans, no VLP-based therapeutic vaccination against self-proteins to modulate chronic
Foerster, John, Molęda, Aleksandra
core   +2 more sources

Restriction of HIV-1 replication in monocytes is abolished by Vpx of SIVsmmPBj [PDF]

open access: yes, 2009
Background: Human primary monocytes are refractory to infection with the human immunodeficiency virus 1 (HIV-1) or transduction with HIV-1-derived vectors.
Silke Schüle   +61 more
core   +2 more sources

A Compensatory Liability Regime to Promote the Exchange of Microbial Genetic Resources for Research and Benefit Sharing [PDF]

open access: yes, 2011
Female rhesus macaques were immunized with HIV virus-like particles (HIV-VLPs) or HIV DNA administered as sequential combinations of mucosal (intranasal) and systemic (intramuscular) routes, according to homologous or heterologous prime-boost schedules ...
Andersen, Hanne   +10 more
core   +2 more sources

The potential for reassortment between Oropouche and Schmallenberg Orthobunyaviruses [PDF]

open access: yes, 2017
A number of viruses within the Peribunyaviridae family are naturally occurring reassortants, a common phenomenon for segmented viruses. Using a minigenome-reporter and virus-like particle (VLP) production assay, we have accessed the potential of ...
Elliott, Richard M.   +3 more
core   +1 more source

Vegetative incompatibility and potential involvement of a mycovirus in the Italian population of Geosmithia morbida [PDF]

open access: yes, 2015
Studies carried out during an Italian outbreak of the Thousand Cankers Disease of walnut, demonstrated that non-coalescing cankers on host plants, separated by equidistant uninfected zones, were associated with incompatible strains of Geosmithia morbida.
Berton, Valeria   +3 more
core   +2 more sources

Unnatural Amino Acid Incorporation into Virus-Like Particles [PDF]

open access: yes, 2008
Virus-like particles composed of hepatitis B virus (HBV) or bacteriophage Qβ capsid proteins have been labeled with azide- or alkyne-containing unnatural amino acids by expression in a methionine auxotrophic strain of E. coli.
Brown, Steven   +11 more
core   +2 more sources

Zika virus like particles elicit protective antibodies in mice. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2018
Mosquito-borne Zika virus (ZIKV) typically causes a mild and self-limiting illness known as Zika fever. Since its recent emergence in 2014 in the American continent, ZIKV infection during pregnancy has been closely associated with a wide range of ...
Mauricio A Salvo   +4 more
doaj   +1 more source

Memory like NK cells display stem cell like properties after Zika virus infection.

open access: yesPLoS Pathogens, 2020
NK cells have been shown to display adaptive traits such as memory formation akin to T and B lymphocytes. Here we show that Zika virus infection induces memory like NK cells that express CD27.
Weshely Kujur   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy